Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Carrier

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Investigation|April 21, 2011
Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in miceChristophe Viret, Stéphane Leung-Theung-Long, Laurent Serre, et al.
Oncogene|July 27, 2005
TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activityRichard Tomasini, Mylène Seux, Jonathan Nowak, et al.
Immunogenetics|October 22, 2002
Expression profiling in mouse fetal thymus reveals clusters of coordinately expressed genes that mark individual stages of T-cell ontogenyMirana Ramialison, Elodie Mohr, Béatrice Nal, et al.
Molecular and Cellular Biology|January 24, 2007
Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1Julien Gommeaux, Carla Cano, Stéphane Garcia, et al.
Scientific Reports|November 20, 2018
Inactivation of NUPR1 promotes cell death by coupling ER-stress responses with necrosisPatricia Santofimia-Castaño, Wenjun Lan, Jennifer Bintz, et al.
The Journal of Biological Chemistry|July 10, 2003
TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activityRichard Tomasini, Amina Azizi Samir, Alice Carrier, et al.
Oncogenesis|December 9, 2025
Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancerNadine Abdel Hadi, Gabriela Reyes-Castellanos, Tristan Gicquel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2018
TP53INP1 deficiency maintains murine B lymphopoiesis in aged bone marrow through redox-controlled IL-7R/STAT5 signalingBochra Zidi, Christelle Vincent-Fabert, Laurent Pouyet, et al.
Results in Immunology|March 7, 2014
Development of an ELISA detecting Tumor Protein 53-Induced Nuclear Protein 1 in serum of prostate cancer patientsHouda Saadi, Marion Seillier, Maria José Sandi, et al.
Scientific Reports|March 24, 2017
Akt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppressionMarion Le Grand, Raphael Berges, Eddy Pasquier, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Investigation|April 21, 2011
Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in miceChristophe Viret, Stéphane Leung-Theung-Long, Laurent Serre, et al.
Oncogene|July 27, 2005
TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activityRichard Tomasini, Mylène Seux, Jonathan Nowak, et al.
Immunogenetics|October 22, 2002
Expression profiling in mouse fetal thymus reveals clusters of coordinately expressed genes that mark individual stages of T-cell ontogenyMirana Ramialison, Elodie Mohr, Béatrice Nal, et al.
Molecular and Cellular Biology|January 24, 2007
Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1Julien Gommeaux, Carla Cano, Stéphane Garcia, et al.
Scientific Reports|November 20, 2018
Inactivation of NUPR1 promotes cell death by coupling ER-stress responses with necrosisPatricia Santofimia-Castaño, Wenjun Lan, Jennifer Bintz, et al.
The Journal of Biological Chemistry|July 10, 2003
TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activityRichard Tomasini, Amina Azizi Samir, Alice Carrier, et al.
Oncogenesis|December 9, 2025
Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancerNadine Abdel Hadi, Gabriela Reyes-Castellanos, Tristan Gicquel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2018
TP53INP1 deficiency maintains murine B lymphopoiesis in aged bone marrow through redox-controlled IL-7R/STAT5 signalingBochra Zidi, Christelle Vincent-Fabert, Laurent Pouyet, et al.
Results in Immunology|March 7, 2014
Development of an ELISA detecting Tumor Protein 53-Induced Nuclear Protein 1 in serum of prostate cancer patientsHouda Saadi, Marion Seillier, Maria José Sandi, et al.
Scientific Reports|March 24, 2017
Akt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppressionMarion Le Grand, Raphael Berges, Eddy Pasquier, et al.
Pageof 5